Journal of Open Source Science
Menu
Home / Identification of a Novel PPAR Signature for Predicting Prognosis, Immune Microenvironment, and Chemotherapy Response in Bladder Cancer.
submitted Original research revision 0 5 days open

Identification of a Novel PPAR Signature for Predicting Prognosis, Immune Microenvironment, and Chemotherapy Response in Bladder Cancer.

Fork this paper

Evidence at a glance

No scientific verdict has been recorded. Explore the available material or start a research fork.

Registered claims
0
Journal analysis runs
0
Research forks opened
0
Paper record The research question, publication details and source material recorded for this paper.

BACKGROUND: Mounting evidence has confirmed that peroxisome proliferator-activated receptors (PPARs) played a crucial role in the development and progression of bladder cancer (BLCA). The purpose of this study is to comprehensively investigate the function and prognostic value of PPAR-targeted genes in BLCA. METHODS: The RNA sequencing data and clinical information of BLCA patients were acquired from The Cancer Genome Atlas (TCGA). The differentially expressed PPAR-targeted genes were investigated. Cox analysis and least absolute shrinkage and selection operator (LASSO) analysis were performed for screening prognostic PPAR-targeted genes and constructing the prognostic PPAR signature and then validated by GSE13507 cohort and GSE32894 cohort. A nomogram was constructed to predict the outcomes of BLCA patients in combination with PPAR signature and clinical factors. Gene set enrichment analysis (GSEA) and immune cell infiltration were implemented to explore the molecular characteristics of the signature. The Genomics of Drug Sensitivity in Cancer (GDSC) database was used to predict the chemotherapy responses of the prognostic signature. The candidate small molecule drugs targeting PPAR-targeted genes were screened by the CMAP database. RESULTS: We constructed and validated the prognostic signature comprising of 4 PPAR-targeted genes (CPT1B, CALR, AHNAK, and FADS2), which was an independent prognostic biomarker in BLCA patients. A nomogram based on the signature and clinical factors was established in the TCGA set, and the calibration plots displayed the excellent predictive capacity. GSEA analysis indicated that PPAR signature was implicated in multiple oncogenic signaling pathways and correlated with tumor immune cell infiltration. Patients in the high-risk groups showed greater sensitivity to chemotherapy than those in the low-risk groups. Moreover, 11 candidate small molecule drugs were identified for the treatment of BLCA. CONCLUSION: We constructed and validated a novel PPAR signature, which showed the excellent performance in predicting prognosis and chemotherapy sensitivity of BLCA patients.

Ke Zhu, Wen Deng, Hui Deng, Xiaoqiang Liu, Gongxian Wang, Bin Fu

Intake
Imported as a canonical record
Recorded by
Journal Editor
Ingest source
PPAR research · pmid:35027921
DOI
10.1155/2021/7056506
Source text held
The abstract only
Data sources Sources named by the paper, including data, code and protocols. Check the recorded access and verification status before preparing a run.

sci_record · open

Corpus Engine

pmid:35027921

version sci 1.2 revision 5 · sha256 sha256:a63979991c40bb01ef19a7869b34502e4d8f9e3fed4e292fd11e80009e6e6c51

Peer review forks Follow attempts to repeat or extend this paper. Each fork records its question, progress and results.

Start a research fork to check a result or build on this work. Choose the result you want to reproduce after signing in.

Sign in to start a fork
The result no result yet The recorded finding, its explanation and the publication decision.

Scientific verdict — what the evidence supports

No scientific verdict

Nothing has been adjudicated on the evidence yet. An editorial decision may still close this record, and that is not a result.

Editorial disposition — what the desk does with it

No disposition

The desk has recorded no decision on this submission.

Assessments and commentary 0 critiques Read model-generated assessments and attributed researcher discussion alongside the recorded results.

Automated assessments

Opinion — non-binding

No automated assessment is available.

no language-model credential is configured, so no machine critique can be produced

No verified model response is available for publication.

Researcher commentary

Opinion — non-binding

No researcher commentary has been recorded yet.

Scope and unresolved questions Review the scope of the analysis, any missing runs and claims that still need evidence.

Out of scope by construction (0)

  • No verdict has been computed, so no scope statement exists yet.

Registered runs that never answered (0)

  • Every registered order produced an accepted attempt.

Registered cells with no evidence (0)

  • Every registered cell carries at least one observation.
Claim map 0 claims What was registered before anything ran: the number to land on, the band it has to land in, and how many runs were promised. The bands were frozen before any output existed, and whether a result falls inside a band is the engine's answer.

This submission carries no registered claim, so no comparison plan exists. The engine refuses to compute a verdict without one.

Registered execution runs 0 runs Every order that was on record before dispatch, and what each one produced. A missing attempt is a discrepancy, not a quiet omission.
Order Condition State Attempts Accepted Observations
No execution order has been registered for this submission.
Ledger events for this receipt 2 events The append-only log behind this record. Each event is hashed and signed and links to the one before it, so the history can be checked rather than trusted.
Seq Event Actor Recorded Event hash
5180 submission.received admin+journal-prd@bntrg.co.uk intake_service 2026-11-04T07:06:16.403999Z c5f9c3aaa792c99fa1d94fa9…
5181 paper.sci_version_held corpus_engine external_service 2026-11-04T07:06:16.413898Z 90a39f65d4857f7c9a70824f…
Downloads and public API Machine-readable records for developers, reuse and independent verification.
Record ID
36b13e61-2354-48f6-a1c7-6900305dac0b
Package hash
17828c25bd8086fb15f7b217ff998cd52c2ec8c8754fae77017f8443efc4e972